EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity

Fatima Maqoud, Francesco Maria Calabrese iD, Giuseppe Celano iD, Domenica Mallardi iD, Francesco Goscilo iD, Benedetta D'Attoma iD, Antonia Ignazzi, Michele Linsalata iD, Gabriele Bitetto, Martina Di Chito, Pasqua Letizia Pesole iD, Arianna Diciolla und 5 weitere

Nutrients · 28.12.2024 · 17 (1) · 72

DOI: 10.3390/nu17010072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 28.12.2024. Verfasst von Fatima Maqoud und 16 weiteren Autor:innen. Beteiligte Einrichtung: Functional Gastrointestinal Disorders Research Group, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari…. Hauptthemen laut MEDLINE: Obesity, Body Mass Index, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health RC 2022-2024, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study explores the link between body mass index (BMI), intestinal permeability, and associated changes in anthropometric and impedance parameters, lipid profiles, inflammatory markers, fecal metabolites, and gut microbiota taxa composition in participants having excessive body mass.

Methods

A cohort of 58 obese individuals with comparable diet, age, and height was divided into three groups based on a priori clustering analyses that fit with BMI class ranges: Group I (25–29.9), Group II (30–39.9), and Group III (>40). Anthropometric and clinical parameters were assessed, including plasma C-reactive protein and cytokine profiles as inflammation markers. Intestinal permeability was measured using a multisaccharide assay, with fecal/serum zonulin and serum claudin-5 and claudin-15 levels. Fecal microbiota composition and metabolomic profiles were analyzed using a phylogenetic microarray and GC-MS techniques.

Results

The statistical analyses of the clinical parameters were based on the full sample set, whereas a subset composed of 37 randomized patients was inspected for the GC/MS metabolite profiling of fecal specimens. An increase in potentially pro-inflammatory bacterial genera (e.g., Slackia, Dorea, Granulicatella) and a reduction in beneficial genera (e.g., Adlercreutzia, Clostridia UCG-014, Roseburia) were measured. The gas chromatography/mass spectrometry analysis of urine samples evidenced a statistically significant increase in m-cymen-8-ol, 1,3,5-Undecatriene, (E, Z) and a decreased concentration of p-cresol, carvone, p-cresol, and nonane.

Conclusions

Together, these data demonstrated how an increased BMI led to significant changes in inflammatory markers, intestinal barrier metabolites, glucose metabolism, endocrine indicators, and fecal metabolomic profiles that can indicate a different metabolite production from gut microbiota. Our findings suggest that targeting intestinal permeability may offer a therapeutic approach to prevent and manage obesity and related metabolic complications, reinforcing the link between gut barrier function and obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityBody Mass IndexGastrointestinal MicrobiomeInflammationIntestinal MucosaHumansMaleFemaleAdultFecesMiddle AgedPermeabilityBiomarkersC-Reactive Protein

Stichwörter der Autor:innen

body mass index (BMI)fecal metabolomicsfecal microbiotainflammatory markersintestinal permeabilityobesityzonulin

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Functional Gastrointestinal Disorders Research Group, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Department of Soil, Plant and Food Science, University of Bari Aldo Moro, 70126 Bari, Italy.
  • Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Core Facility Biobank, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Laboratory of Clinical Pathology, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Scientific Direction, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.

ORCID-Profile: Francesco Maria Calabrese, Giuseppe Celano, Domenica Mallardi, Francesco Goscilo, Benedetta D'Attoma, Michele Linsalata, Pasqua Letizia Pesole, Carmen Aurora Apa, Giovanni De Pergola, Gianluigi Giannelli, Maria De Angelis, Francesco Russo

Förderung

  • Italian Ministry of Health RC 2022-2024
  • Italian Ministry of Health

Zitieren

APA

Maqoud, F., Calabrese, F. M., Celano, G., Mallardi, D., Goscilo, F., D'Attoma, B., Ignazzi, A., Linsalata, M., Bitetto, G., Di Chito, M., Pesole, P. L., Diciolla, A., Apa, C. A., De Pergola, G., Giannelli, G., De Angelis, M., & Russo, F. (2024). Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity. Nutrients, 17(1), 72. https://doi.org/10.3390/nu17010072

Vancouver

Maqoud F, Calabrese FM, Celano G, Mallardi D, Goscilo F, D'Attoma B, et al. Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity. Nutrients. 2024;17(1):72. doi:10.3390/nu17010072

BibTeX
@article{Maqoud2024,
  author = {Maqoud, Fatima and Calabrese, Francesco Maria and Celano, Giuseppe and Mallardi, Domenica and Goscilo, Francesco and D'Attoma, Benedetta and Ignazzi, Antonia and Linsalata, Michele and Bitetto, Gabriele and Di Chito, Martina and Pesole, Pasqua Letizia and Diciolla, Arianna and Apa, Carmen Aurora and De Pergola, Giovanni and Giannelli, Gianluigi and De Angelis, Maria and Russo, Francesco},
  title = {Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity},
  journal = {Nutrients},
  year = {2024},
  volume = {17},
  number = {1},
  pages = {72},
  doi = {10.3390/nu17010072}
}
Kostenlos starten →